🇺🇸 FDA
Pipeline program

Xuebijing Injection

2017ZDSYLL025-P01

Approved small_molecule completed

Quick answer

Xuebijing Injection for Sepsis is a Approved program (small_molecule) at Xiyuan Hospital of China Academy of Chinese Medical Sciences with 2 ClinicalTrials.gov record(s).

Program details

Company
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Indication
Sepsis
Phase
Approved
Modality
small_molecule
Status
completed

Clinical trials